Hatanaka, T.; Yata, Y.; Naganuma, A.; Kakizaki, S.
Treatment Strategy for Intermediate-Stage Hepatocellular Carcinoma: Transarterial Chemoembolization, Systemic Therapy, and Conversion Therapy. Cancers 2023, 15, 1798.
https://doi.org/10.3390/cancers15061798
AMA Style
Hatanaka T, Yata Y, Naganuma A, Kakizaki S.
Treatment Strategy for Intermediate-Stage Hepatocellular Carcinoma: Transarterial Chemoembolization, Systemic Therapy, and Conversion Therapy. Cancers. 2023; 15(6):1798.
https://doi.org/10.3390/cancers15061798
Chicago/Turabian Style
Hatanaka, Takeshi, Yutaka Yata, Atsushi Naganuma, and Satoru Kakizaki.
2023. "Treatment Strategy for Intermediate-Stage Hepatocellular Carcinoma: Transarterial Chemoembolization, Systemic Therapy, and Conversion Therapy" Cancers 15, no. 6: 1798.
https://doi.org/10.3390/cancers15061798
APA Style
Hatanaka, T., Yata, Y., Naganuma, A., & Kakizaki, S.
(2023). Treatment Strategy for Intermediate-Stage Hepatocellular Carcinoma: Transarterial Chemoembolization, Systemic Therapy, and Conversion Therapy. Cancers, 15(6), 1798.
https://doi.org/10.3390/cancers15061798